Cardiovascular
Read More about this categoryShow Less
Cardiovascular
The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment.
Research Areas
- Acute Phase Reactants(15)
- Angina(14)
- Arrhythmia(82)
- Atherosclerosis(88)
- Chronic Kidney Disease(18)
- Coagulation & Hemostasis(124)
- Coronary Artery Disease(7)
- Diabetic Nephropathy(8)
- Endothelium(33)
- Erythrocytes & Hemoglobin(49)
- Heart Failure(33)
- Hypertension(162)
- Hypotension(24)
- Lipoproteins(61)
- Myocardial Contractility(33)
- Myocardial Hypertrophy(21)
- Myocardial Infarction(61)
- Others(1)
- Serum Proteins(11)
- Smooth Muscle Cells(36)
- Storage & Transport(6)
- Stroke(48)
- Thrombosis(52)
- Vasoconstriction(59)
- Vasodilation(141)
- Cardiomyopathy(5)
- Cholesterol Metabolism(44)
Products Related to Cardiovascular(821)
- GC49343Isoproterenol-d7 (hydrochloride)CAS: 2517584-04-0Purity: >99.00%
An internal standard for the quantification of isoproterenol
- GC493461-(3-Chlorophenyl)biguanide (hydrochloride)CAS: 2113-05-5Purity: >95.00%
A 5-HT 3 receptor agonist
- GC49358Sildenafil ChlorosulfonylCAS: 139756-22-2Purity: >98.00%
An intermediate in the synthesis of sildenafil
- GC49374L-Arginine-d7 (hydrochloride)CAS: 204244-77-9Purity: >99.00%
An internal standard for the quantification of L-arginine
- GC49376DL-Aspartic Acid-d3CAS: 14341-75-4Purity: >99.00%
An internal standard for the quantification of aspartic acid
- GC49377L-Glutamine-d5CAS: 14341-78-7Purity: >99.00%
An internal standard for the quantification of L-glutamine
- GC49387Berberine-d6 (chloride)Purity: >99.00%
An internal standard for the quantification of berberine
- GC49389Tritylolmesartan MedoxomilCAS: 144690-92-6Purity: >98.00%
An intermediate in the synthesis of olmesartan medoxomil
- GC49399N-Desbutyl Dronedarone (hydrochloride)CAS: 197431-02-0Purity: >95.00%
Debutyldronedarone (SR35021) hydrochloride, the main metabolite of Dronedarone, is a selective thyroid hormone receptor α1 (TRα1) inhibitor.
- GC49408Ramipril Diketopiperazine AcidCAS: 108736-10-3Purity: >95.00%
A potential impurity found in commercial preparations of ramipril
- GC49413Rizatriptan N-oxideCAS: 260435-42-5Purity: >90.00%
A potential impurity found in commercial preparations of rizatriptan
- GC49421Atorvastatin lactone-d5CAS: 125995-03-1Purity: >99.00%
An internal standard for the quantification of atorvastatin lactone
- GC49424Pyridostigmine-d3 (bromide)Purity: >99.00%
An internal standard for the quantification of pyridostigmine
- GC49428O-Des[2-aminoethyl]-O-carboxymethyl dehydroamlodipineCAS: 113994-45-9Purity: >95.00%
A major metabolite of amlodipine
- GC49436L-3-n-ButylphthalideCAS: 3413-15-8Purity: >99.00%
A phthalide with antiplatelet and neuroprotective activities
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC49343 | Isoproterenol-d7 (hydrochloride) | 2517584-04-0 | >99.00% | |
An internal standard for the quantification of isoproterenol | ||||
| GC49346 | 1-(3-Chlorophenyl)biguanide (hydrochloride) | 2113-05-5 | >95.00% | |
A 5-HT 3 receptor agonist | ||||
| GC49349 | O-Desethyl Sildenafil | 139755-91-2 | >95.00% | |
A metabolite of sildenafil | ||||
| GC49358 | Sildenafil Chlorosulfonyl | 139756-22-2 | >98.00% | |
An intermediate in the synthesis of sildenafil | ||||
| GC49374 | L-Arginine-d7 (hydrochloride) | 204244-77-9 | >99.00% | |
An internal standard for the quantification of L-arginine | ||||
| GC49376 | DL-Aspartic Acid-d3 | 14341-75-4 | >99.00% | |
An internal standard for the quantification of aspartic acid | ||||
| GC49377 | L-Glutamine-d5 | 14341-78-7 | >99.00% | |
An internal standard for the quantification of L-glutamine | ||||
| GC49386 | Tepoxalin | 103475-41-8 | >98.00% | |
A dual inhibitor of COX and 5-LO | ||||
| GC49387 | Berberine-d6 (chloride) | - | >99.00% | |
An internal standard for the quantification of berberine | ||||
| GC49389 | Tritylolmesartan Medoxomil | 144690-92-6 | >98.00% | |
An intermediate in the synthesis of olmesartan medoxomil | ||||
| GC49399 | N-Desbutyl Dronedarone (hydrochloride) | 197431-02-0 | >95.00% | |
Debutyldronedarone (SR35021) hydrochloride, the main metabolite of Dronedarone, is a selective thyroid hormone receptor α1 (TRα1) inhibitor. | ||||
| GC49403 | Benzarone | 1477-19-6 | >98.00% | |
An active metabolite of benzbromarone | ||||
| GC49406 | ACT-373898 | 1433875-14-9 | >90.00% | |
A metabolite of macitentan | ||||
| GC49408 | Ramipril Diketopiperazine Acid | 108736-10-3 | >95.00% | |
A potential impurity found in commercial preparations of ramipril | ||||
| GC49409 | Desmethyl Ranolazine | 172430-45-4 | >95.00% | |
A metabolite of ranolazine | ||||
| GC49410 | CVT-2738 | 5294-61-1 | >98.00% | |
An active metabolite of ranolazine | ||||
| GC49413 | Rizatriptan N-oxide | 260435-42-5 | >90.00% | |
A potential impurity found in commercial preparations of rizatriptan | ||||
| GC49414 | p-Cresol Glucuronide | 17680-99-8 | >98.00% | |
A metabolite of p -cresol | ||||
| GC49416 | Gap 27 (trifluoroacetate salt) | - | >98.00% | |
A connexin-mimetic peptide | ||||
| GC49421 | Atorvastatin lactone-d5 | 125995-03-1 | >99.00% | |
An internal standard for the quantification of atorvastatin lactone | ||||
| GC49424 | Pyridostigmine-d3 (bromide) | - | >99.00% | |
An internal standard for the quantification of pyridostigmine | ||||
| GC49428 | O-Des[2-aminoethyl]-O-carboxymethyl dehydroamlodipine | 113994-45-9 | >95.00% | |
A major metabolite of amlodipine | ||||
| GC49433 | Capsiate | 205687-01-0 | >85.00% | |
A capsaicin analog with diverse biological activities | ||||
| GC49436 | L-3-n-Butylphthalide | 3413-15-8 | >99.00% | |
A phthalide with antiplatelet and neuroprotective activities | ||||